Acylated ghrelin: A potential marker for fibromyalgia?

European Journal of Pain (United Kingdom)

Volumn 17, Issue 8, 2013, Pages 1216-1224

  Homann, Diogo ^a   Louzada, F M ^a   Goes S M ^a   Roizenblatt, S ^b   Lopes, A L ^c   De Oliveira, A R ^c   Leite, N ^a  

^a FEDERAL UNIVERSITY OF PARANÁ   (Brazil)

^b FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^c FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ACYLATION; ADULT; BIOLOGICAL MARKERS; BLOOD GLUCOSE; FEMALE; FIBROMYALGIA; GHRELIN; HUMANS; LEPTIN; MIDDLE AGED; OBESITY;

EID: 84894158304     PISSN: 10903801     EISSN: 15322149     Source Type: Journal    
DOI: 10.1002/j.1532-2149.2013.00296.x     Document Type: Article

References (51)

1. Beccuti, G., Pannain, S. (2011). Sleep and obesity. Curr Opin Clin Nutr Metab Care 14, 402-412.
2. Bedaiwy, M.A., Falcone, T., Goldberg, J.M., Sharma, R.K., Nelson, D.R., Agarwal, A. (2006). Peritoneal fluid leptin is associated with chronic pelvic pain but not infertility in endometriosis patients. Hum Reprod 21, 788-791.
3. Bennett, R.M., Jones, J., Turk, D.C., Russell, I.J., Matallana, L. (2007). An internet survey of 2, 596 people with fibromyalgia. BMC Musculoskelet Disord 8, 27.
4. Bingefors, K., Isacson, D. (2004). Epidemiology, co-morbidity, and impact on health-related quality of life of self-reported headache and musculoskeletal pain-a gender perspective. Eur J Pain 8, 435-450.
5. Bloom, F., Battenberg, E., Rossier, J., Ling, N., Guillemin, R. (1978). Neurons containing beta-endorphin in rat brain exist separately from those containing enkephalin: Immunocytochemical studies. Proc Natl Acad Sci U S A 75, 1591-1595.
6. Cappuccio, F.P., Taggart, F.M., Kandala, N.B., Currie, A., Peile, E., Stranges, S., Miller, M.A. (2008). Meta-analysis of short sleep duration and obesity in children and adults. Sleep 31, 619-626.
7. Chiu, Y.H., Silman, A.J., Macfarlane, G.J., Ray, D., Gupta, A., Dickens, C., Morriss, R., McBeth, J. (2005). Poor sleep and depression are independently associated with a reduced pain threshold. Results of a population based study. Pain 115, 316-321.
8. Clauw, D.J. (2009). Fibromyalgia: An overview. Am J Med 122, S3-S13.
9. Craig, C.L., Marshall, A.L., Sjöström, M., Bauman, A.E., Booth, M.L., Ainsworth, B.E., Pratt, M., Ekelund, U., Yngve, A., Sallis, J.F., Oja, P. (2003). International physical activity questionnaire: 12-country reliability and validity. Med Sci Sports Exerc 35, 1381-1395.
10. Dieguez, C., Casanueva, F.F. (2000). Ghrelin: A step forward in the understanding of somatotroph cell function and growth regulation. Eur J Endocrinol 142, 413-417.
11. Doupis, J., Lyons, T.E., Wu, S., Gnardellis, C., Dinh, T., Veves, A. (2009). Microvascular reactivity and inflammatory cytokines in painful and painless peripheral diabetic neuropathy. J Clin Endocrinol Metab 94, 2157-2163.
12. Edwards, R.R., Almeida, D.M., Klick, B., Haythornthwaite, J.A., Smith, M.T. (2008). Duration of sleep contributes to next-day pain report in the general population. Pain 137, 202-207.
13. Fietta, P., Fietta, P. (2006). Counterbalance between leptin and cortisol may be associated with fibromyalgia. Psychiatry Clin Neurosci 60, 529.
14. Guan, X.M., Yu, H., Palyha, O.C., McKee, K.K., Feighner, S.D., Sirinathsinghji, D.J., Smith, R.G., Van Der Ploeg, L.H., Howard, A.D. (1997). Distribution of mRNA encoding the growth hormone secretagogue receptor in brain and peripheral tissues. Brain Res Mol Brain Res 48, 23-29.
15. Guneli, E., Gumustekin, M., Ates, M. (2010b). Possible involvement of ghrelin on pain threshold in obesity. Med Hypotheses 74, 452-454.
16. Guneli, E., Onal, A., Ates, M., Bagriyanik, H.A., Resmi, H., Orhan, C.E., Kolatan, H.E., Gumustekin, M. (2010a). Effects of repeated administered ghrelin on chronic constriction injury of the sciatic nerve in rats. Neurosci Lett 479, 226-230.
17. Janke, E.A., Collins, A., Kozak, A.T. (2007). Overview of the relationship between pain and obesity: What do we know? Where do we go next? J Rehabil Res Dev 44, 245-262.
18. Jean-Louis, G., Kripke, D.F., Mason, W.J., Elliot, J.A., Youngstedt, S.D. (2001). Sleep estimation from wrist movement quantified by different actigraphic modalities. J Neurosci Methods 105, 185-191.
19. Jensen, M.P., Turner, J.A., Romano, J.M., Fisher, L.D. (1999). Comparative reliability and validity of chronic pain intensity measures. Pain 83, 157-162.
20. Julien, N., Goffaux, P., Arsenault, P., Marchand, S. (2005). Widespread pain in fibromyalgia is related to a deficit of endogenous pain inhibition. Pain 114, 295-302.
21. Kelesidis, T., Kelesidis, I., Chou, S., Mantzoros, C.S. (2010). Narrative review: The role of leptin in human physiology: Emerging clinical applications. Ann Intern Med 152, 93-100.
22. Kim, C.H., Luedtke, C.A., Vincent, A., Thompson, J.M., Oh, T.H. (2012a). The association of body mass index with symptom severity and quality of life in patients with fibromyalgia. Arthritis Care Res (Hoboken) 64, 222-228.
23. Kim, Y.S., Lee, J.S., Lee, T.H., Cho, J.Y., Kim, J.O., Kim, W.J., Kim, H.G., Jeon, S.R., Jeong, H.S. (2012b). Plasma levels of acylated ghrelin in patients with functional dyspepsia. World J Gastroenterol 18, 2231-2237.
24. Kojima, M., Hosoda, H., Date, Y., Nakazato, M., Matsuo, H., Kangawa, K. (1999). Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature 402, 656-660.
25. Korbonits, M., Bustin, S.A., Kojima, M., Jordan, S., Adams, E.F., Lowe, D.G., Kangawa, K., Grossman, A.B. (2001). The expression of the growth hormone secretagogue receptor ligand ghrelin in normal and abnormal human pituitary and other neuroendocrine tumors. J Clin Endocrinol Metab 86, 881-887.
26. Lim, G., Wang, S., Zhang, Y., Tian, Y., Mao, J. (2009). Spinal leptin contributes to the pathogenesis of neuropathic pain in rodents. J Clin Invest 119, 295-304.
27. Maeda, T., Kiguchi, N., Kobayashi, Y., Ikuta, T., Ozaki, M., Kishioka, S. (2009). Leptin derived from adipocytes in injured peripheral nerves facilitates development of neuropathic pain via macrophage stimulation. Proc Natl Acad Sci U S A 106, 13076-13081.
28. Mork, P.J., Vasseljen, O., Nilsen, T.I. (2010). Association between physical exercise, body mass index, and risk of fibromyalgia: Longitudinal data from the Norwegian Nord-Trøndelag Health Study. Arthritis Care Res (Hoboken) 62, 611-617.
29. Neumann, L., Lerner, E., Glazer, Y., Bolotin, A., Shefer, A., Buskila, D. (2008). A cross-sectional study of the relationship between body mass index and clinical characteristics, tenderness measures, quality of life, and physical functioning in fibromyalgia patients. Clin Rheumatol 27, 1543-1547.
30. Okifuji, A., Donaldson, G.W., Barck, L., Fine, P.G. (2010). Relationship between fibromyalgia and obesity in pain, function, mood, and sleep. J Pain 11, 1329-1337.
31. Otero, M., Nogueiras, R., Lago, F., Meijide, J., Amarelo, J., Mera, A., Gomez-Reino, J., Gualillo, O. (2005). Ghrelin plasmatic levels in patients with fibromyalgia. Rheumatol Int 25, 6-8.
32. Pardini, R., Matsudo, S., Araújo, T., Matsudo, V., Andrade, E., Braggion, G., Andrade, D., Oliveira, L., Figueira Jr, A., Raso, V. (2001). Validation of the International Physical Activity Questionaire (IPAQ version 6): Pilot study in Brazilian young adults] [Portuguese]. Rev Bras Ciênc Mov 9, 45-51.
33. Peltonen, M., Lindroos, A.K., Torgerson, J.S. (2003). Musculoskeletal pain in the obese: A comparison with a general population and long-term changes after conventional and surgical obesity treatment. Pain 104, 549-557.
34. Riediger, T., Traebert, M., Schmid, H.A., Scheel, C., Lutz, T.A., Scharrer, E. (2003). Site-specific effects of ghrelin on the neuronal activity in the hypothalamic arcuate nucleus. Neurosci Lett 341, 151-155.
35. Saber, A.A., Boros, M.J., Mancl, T., Elgamal, M.H., Song, S., Wisadrattanapong, T. (2008). The effect of laparoscopic Roux-en-Y gastric bypass on fibromyalgia. Obes Surg 18, 652-655.
36. Schüssler, P., Uhr, M., Ising, M., Weikel, J.C., Schmid, D.A., Held, K., Mathias, S., Steiger, A. (2006). Nocturnal ghrelin, ACTH, GH and cortisol secretion after sleep deprivation in humans. Psychoneuroendocrinology 31, 915-923.
37. Shapiro, J.R., Anderson, D.A., Danoff-Burg, S. (2005). A pilot study of the effects of behavioral weight loss treatment on fibromyalgia symptoms. J Psychosom Res 59, 275-282.
38. Sibilia, V., Lattuada, N., Rapetti, D., Pagani, F., Vincenza, D., Bulgarelli, I., Locatelli, V., Guidobono, F., Netti, C. (2006). Ghrelin inhibits inflammatory pain in rats: Involvement of the opioid system. Neuropharmacology 51, 497-505.
39. Taheri, S., Lin, L., Austin, D., Young, T., Mignot, E. (2004). Short sleep duration is associated with reduced leptin, elevated ghrelin, and increased body mass index. PLoS Med 1, e62.
40. Tamashiro, K.L., Sakai, R.R., Shively, C.A., Karatsoreos, I.N., Reagan, L.P. (2011). Chronic stress, metabolism, and metabolic syndrome. Stress 14, 468-474.
41. Tander, B., Atmaca, A., Aliyazicioglu, Y., Canturk, F. (2007). Serum ghrelin levels but not GH, IGF-1 and IGFBP-3 levels are altered in patients with fibromyalgia syndrome. Joint Bone Spine 74, 477-481.
42. Tian, Y., Wang, S., Ma, Y., Lim, G., Kim, H., Mao, J. (2011). Leptin enhances NMDA-induced spinal excitation in rats: A functional link between adipocytokine and neuropathic pain. Pain 152, 1263-1271.
43. Ursini, F., Naty, S., Grembiale, R.D. (2011). Fibromyalgia and obesity: The hidden link. Rheumatol Int 31, 1403-1408.
44. Van Der Lely, A.J., Tschöp, M., Heiman, M.L., Ghigo, E. (2004). Biological, physiological, pathophysiological, and pharmacological aspects of ghrelin. Endocr Rev 25, 426-457.
45. Vergnano, A.M., Ferrini, F., Salio, C., Lossi, L., Baratta, M., Merighi, A. (2008). The gastrointestinal hormone ghrelin modulates inhibitory neurotransmission in deep laminae of mouse spinal cord dorsal horn. Endocrinology 149, 2306-2312.
46. Weikel, J.C., Wichniak, A., Ising, M., Brunner, H., Friess, E., Held, K., Mathias, S., Schmid, D.A., Uhr, M., Steiger, A. (2003). Ghrelin promotes slow-wave sleep in humans. Am J Physiol Endocrinol Metab 284, E407-E415.
47. Wolfe, F., Clauw, D.J., Fitzcharles, M.A., Goldenberg, D.L., Katz, R.S., Mease, P., Russell, A.S., Russell, I.J., Winfield, J.B., Yunus, M.B. (2010). The American College of Rheumatology preliminary diagnostic criteria for fibromyalgia and measurement of symptom severity. Arthritis Care Res (Hoboken) 62, 600-610.
48. Wolfe, F., Smythe, H.A., Yunus, M.B., Bennett, R.M., Bombardier, C., Goldenberg, D.L., Tugwell, P., Campbell, S.M., Abeles, M., Clark, P., Fam, A.G., Farber, S.J., Fiechtner, J.J., Franklin, C.M., Gatter, R.A., Hamaty, D., Lessard, J., Lichtbroun, A.S., Masi, A.T., Mccain, G.A., Reynolds, W.J., Romano, T.J., Russell, I.J., Sheon, R.P. (1990). The American College of Rheumatology 1990 criteria for the classification of fibromyalgia. Report of the multicenter criteria committee. Arthritis Rheum 33, 160-172.
49. Yunus, M.B., Arslan, S., Aldag, J.C. (2002). Relationship between body mass index and fibromyalgia features. Scand J Rheumatol 31, 27-31.
50. Zhang, Y., Proenca, R., Maffei, M., Barone, M., Leopold, L., Friedman, J.M. (1994). Positional cloning of the mouse obese gene and its human homologue. Nature 372, 425-432.
51. Zigman, J.M., Jones, J.E., Lee, C.E., Saper, C.B., Elmquist, J.K. (2006). Expression of ghrelin receptor mRNA in the rat and the mouse brain. J Comp Neurol 494, 528-548.